Song R, Harding C V
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
J Immunol. 1996 Jun 1;156(11):4182-90.
Latex-OVA and bacteria expressing an OVA fusion protein were processed by macrophages via an alternate class I MHC (MHC-I) processing pathway to present OVA(257-264):Kb. This pathway was resistant to dipeptide aldehyde proteasome inhibitors and brefeldin A, unlike the cytosolic MHC-I pathway. TAP1-/- macrophages exhibited decreases in cell surface peptide-receptive MHC-I and binding of extracellular peptide during transient incubations. This may explain an apparent influence of TAP on alternate MHC-I processing. Alternate MHC-I processing by TAP1-/- cells was enhanced by preincubation at 26 degrees C or with beta 2-microglobulin to increase peptide-receptive MHC-I. Thus, peptides may bind to MHC-I within post-Golgi vacuolar organelles accessible to exogenous beta 2-microglobulin or on the cell surface (following peptide regurgitation).
表达OVA融合蛋白的乳胶-OVA和细菌通过替代性I类主要组织相容性复合体(MHC-I)加工途径被巨噬细胞处理,以呈递OVA(257 - 264):Kb。与胞质MHC-I途径不同,该途径对二肽醛蛋白酶体抑制剂和布雷菲德菌素A具有抗性。在短暂孵育期间,TAP1基因敲除的巨噬细胞表现出细胞表面肽受体MHC-I减少以及细胞外肽结合减少。这可能解释了TAP对替代性MHC-I加工的明显影响。通过在26℃预孵育或与β2微球蛋白一起预孵育以增加肽受体MHC-I,可增强TAP1基因敲除细胞的替代性MHC-I加工。因此,肽可能在高尔基体后液泡细胞器内与可被外源性β2微球蛋白接近的MHC-I结合,或在细胞表面(肽反流后)结合。